CASP3 and neoplasm: Consistently, treated tumours displayed reduced proliferation (Ki67) by 42% and increased apoptosis (cleaved caspase-3) by 87% (Fig. 8f), suggesting that MAb5204 antibody treatment reduces tumour growth.